• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Cold Chain Packaging and Logistics

    How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

    Challenges of Preparing Highly Potent Oral Products

    Bioprocessing Trends

    Sustainable Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    groninger Continues Growth in the US

    Catalent Bolsters Cell and Gene Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    What Does the Future of API Synthesis Look Like?

    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Jaguar Health Achieves Key Milestone for Crofelemer API Manufacturer
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Bolsters Cell and Gene Services

    CDMO Sirio Pharma Completes the Acquisition of Best Formulations

    Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1

    Case Study: Secondary Sourcing Strategies to Ensure Supply Chain Security

    Beat the Supply Chain Backlog
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Catalent Bolsters Cell and Gene Services

    Crown Bioscience to Acquire Indivumed’s Service Biz and Supporting Biobank

    Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

    Understanding the Essential Role of a Qualified Person

    Altasciences Los Angeles Clinical Site Receives CAP Accreditation
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Chiron Recombinant Proteins

    Bachem

    LOTTE BIOLOGICS

    Quotient Sciences

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Chiron Recombinant Proteins

    Bachem

    LOTTE BIOLOGICS

    Quotient Sciences

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Virtual Clinical Trials: The Future of Dermatology Studies

    COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.

    Virtual Clinical Trials: The Future of Dermatology Studies
    Related CONTENT
    • Stiris Research Inc.
    • pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    • Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
    • Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    • Clean Cells Expands Bioproduction Capabilities
    Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech01.15.21
    COVID-19 has created lasting impacts for clinical trials worldwide. Many pharmaceutical companies have had to rapidly implement innovative solutions to allow their clinical trials to continue, including adapting various aspects to be carried out in the safety of a patient’s home. Virtual and hybrid clinical trials have quickly become a necessity.

    A host of benefits have arisen from the adoption of virtual clinical trials. The reduced number of site visits can decrease site burden, remove barriers to participation, and widen the pool of eligible patients. With these advantages, it is clear that decentralized clinical trials will continue to be a viable option beyond the pandemic. Although it is not realistic to assume all clinical trials can be made completely virtual, it may be suitable to implement aspects of virtual trials as a hybrid approach. Notably, dermatology trials can be particularly well-suited to a hybrid virtual trial design. Dermatology assessments are often less complex than other therapeutic areas, and the visual aspect of evaluating and identifying skin conditions is adaptable to virtual models.

    Furthermore, as dermatology conditions are rarely life-threatening, patients are more likely to engage with trials if they can work around their other commitments, and virtual trials bring more convenience than traditional approaches.

    Methods and tools to help adopt a virtual approach

    Patient recruitment during and beyond a COVID-19 world

    Adopting a virtual approach starts with enrollment. Currently, patient recruitment is the single biggest cause of delays in clinical trials, leading to lost revenue for pharmaceutical companies.1 As we know, it is important for clinical trials in dermatology to have a digital recruitment presence. This is partly because more than 80% of internet users turn to the internet to find healthcare information, including millions of searches a month on eczema alone.1 Now, with reduced face-to-face healthcare interactions as a result of the pandemic, it’s essential that digital patient recruitment strategies are carried through to virtual trials in order to widen the pool of potential participants. It is also important to share relevant information with potential participants, such as the study duration and procedures involved, which can be done virtually. Patients visiting web pages and recruitment ads can be redirected to nurse call centers where they can receive guidance on completing online pre-screening questionnaires and further information on the study. Following these calls, nurses can then refer the patient to study sites to determine their eligibility.

    Patient data collection from the safety of patients’ homes

    Initial screening assessments can often be done virtually, and throughout the clinical trial participants can continue to record clinical data from home. By using data collection tools, such as eDiaries, on patients’ own devices, data is captured in real time and can be sent straight to site staff. Not only is this more convenient for the patient, but it can increase data quality and allows study sponsors to instantly access study trends. This is important in dermatology studies as patient-reported quality of life data are generally used in combination with disease-specific instruments, such as the Psoriasis Area and Severity Index (PASI) and the Eczema Area and Severity Index (EASI). If adverse reactions do occur, participants can record this themselves more accurately than relying on recall in a face-to-face appointment. Photographic images can be sent to site study staff for evaluation, and advice can be given to the patient immediately.

    Images can also be used in visual assessments and to help determine diagnostic endpoints, leading to utilization of central review options and reducing variability between sites.
    The use of wearable technology is also gaining traction within clinical trials. Wearable devices, such as smart watches, can record vital signs in real time and send this data directly to site staff. This real-time data can provide regulators and payers with meaningful insights into the impacts of the study drug in the real world.2

    Looking beyond technology, home visits allow blood samples to be collected without subjects having to leave their homes. Healthcare professionals can also bring the study treatment to a patient’s home, which is valuable where self-administration is difficult. This may help boost patient retention, considering some patients still prefer the human connection of face-to-face interactions with healthcare professionals. Alternatively, the study treatment may be shipped directly to the patient’s home, which has the added benefit of greater patient engagement.3

    Continuing clinical trials with patients at the core

    In the midst of enthusiasm around advancing clinical trials, the patient experience should remain the priority. Fortunately, adopting virtual elements in clinical trials can help improve the patient experience during the entire process. The implementation of digital study platforms allows patients to have 24/7 access to information about the trial, can be used to send reminders to take their study drug or complete questionnaires, and much more. The IQVIA Study Hub platform connects patients, investigators, and local providers on the same platform. The platform is accessible through an application, which can be used to schedule site visits, telehealth appointments, and to integrate smart watch data. As a result, patients have clear study information, regular support from healthcare staff, and shorter appointments, which can be scheduled outside of working hours.4 Consequently, there are advantages to all stakeholders, because improving the patient experience leads to greater adherence to the study protocol.5 Furthermore, as up to 40% of patients are estimated to drop out of clinical trials before the completion date,1 it is beneficial to implement a patient engagement platform that keeps motivation high.

    Virtual trials and technology are gaining acceptance among patients and sites, and patients are adjusting well throughout the pandemic. Greater acceptance has been seen among older adults as they are also becoming more comfortable using technology in their everyday lives.

    Going virtual: what next?

    Every clinical trial is different. An analysis of the protocol, followed by a tailored approach, is needed to establish which components of the trial could be made virtual, and what must happen on site. Ultimately, it is vital to find a partner who understands the custom and delicate balance of virtual versus traditional clinical trial components, based on the study population, severity of indication, the study endpoints, and more.

    Challenging times call for innovative solutions. COVID-19 has helped facilitate new approaches to clinical trial conduct. Breathing new life into outdated clinical trial practices in the form of decentralization can help increase enrollment, patient retention and satisfaction, all while maintaining the highest data quality.

    References:
    1. Industry Standards Research. The expanding web of clinical trial patient recruitment. 2014. Available at: http://isrreports.com/wp-content/uploads/2014/04/ISR-The-Expanding-Web-of-Clinical-Trial-Patient-Recruitment-Whitepaper.pdf
    2. Beckstrom K. Wearables in clinical trials: where we’re heading. 2019. Available at: https://www.ert.com/blog/wearables-in-clinical-trials-where-were-heading/
    3. Taylor, A. Exploring the key considerations for direct-to-patient shipping. 2017. Available at: https://www.clinicaltrialsarena.com/news/exploring-the-key-considerations-for-direct-to-patient-shipping-5739643-2/
    4. Henshall C, Narendran P, Andrews RC, Daley A, Stokes KA, Kennedy A, Greenfield S. Qualitative study of barriers to clinical trial retention in adults with recently diagnosed type 1 diabetes. BMJ Open. 2018;8(7). Available at: https://bmjopen.bmj.com/content/8/7/e022353.long
    5. Pfammatter AF, Mitsos A, Wang S, Hood SH, Spring B. Evaluating and improving recruitment and retention in an mHealth clinical trial: an example of iterating methods during a trial. Mhealth. 2017;1;3:49. Available at: http://mhealth.amegroups.com/article/view/17200/17571



    Sonja VanWye has more than 30 years in the healthcare field including global pharmaceutical drug development with biopharmaceutical companies and CROs. She serves as Director of Dermatology Strategy for IQVIA Biotech with core responsibilities as a strategic consultant for study strategy and proposal development oversight. Her previous positions span a range of functions, including project management and quality assurance. With 17 years working with dermatology early and late phase trials, Sonja brings expertise on combining study conduct requirements with new and innovative technologies to deliver study strategies that support successful trial completion. 
    Related Searches
    • Clinical Trials
    • Drug Development
    • Information Technology
    Suggested For You
    Stiris Research Inc. Stiris Research Inc.
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities
    CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    Lakes BioScience Signs Agreement with Cytvia Lakes BioScience Signs Agreement with Cytvia
    Boyds Opens US Office in PA Boyds Opens US Office in PA
    Repligen and Navigo Launch Antibody Technology Platform Repligen and Navigo Launch Antibody Technology Platform
    Boehringer Ingelheim, Twist Bioscience Enter Antibody Discovery Collaboration Boehringer Ingelheim, Twist Bioscience Enter Antibody Discovery Collaboration
    GeneQuine, Exothera Enter Gene Therapy Partnership GeneQuine, Exothera Enter Gene Therapy Partnership
    GeneQuine Contracts Exothera to Support the Development of Its Osteoarthritis Gene Therapy GeneQuine Contracts Exothera to Support the Development of Its Osteoarthritis Gene Therapy
    Gaston Salinas Botanical Solution Inc. Gaston Salinas Botanical Solution Inc.
    Trust, but Verify Trust, but Verify
    Let’s Get Genuine Let’s Get Genuine

    Related Buyers Guide Companies

    • Stiris Research Inc.

      ...
      Denise Palmer, Manager, Business Development 11.04.22

    • Breaking News | Clinical Trials
      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.
      09.22.21

    • Biologics, Proteins, Vaccines | Breaking News | Clinical Trials
      Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany

      Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany

      Covers the combination of DHODH inhibitors and nucleoside analogues to treat viral infections, including Covid-19.
      09.22.21


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
      Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate

      Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate

      Will initiate the GMP manufacturing of the clinical batches of FluGen’s M2SR influenza vaccine candidate for upcoming clinical trials.
      09.21.21

    • Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Clean Cells Expands Bioproduction Capabilities

      Clean Cells Expands Bioproduction Capabilities

      Invests $15.3 million in new biopharmaceutical production site.
      09.16.21

    Loading, Please Wait..
    Trending
    • Sarepta And Catalent Expand Manufacturing Partnership
    • Forge Biologics Strengthens Genetic Medicine CDMO Capabilities
    • Colorcon Signs Agreement To Purchase Airnov Healthcare Packaging
    • The Ongoing Evolution And Implementation Of DCTs In 2023
    • EyePoint Pharmaceuticals To Build GMP Mfg. Facility In Northbridge, MA
    Breaking News
    • Pasithea Signs CMC Development and Manufacturing Agreement
    • Experic Expands Analytical Capabilities and Facilities
    • List Labs Expands Manufacturing Capacity
    • groninger Continues Growth in the US
    • Catalent Bolsters Cell and Gene Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2022

    • Cold Chain Packaging and Logistics
    • Optimizing Supply Chains for Allogeneic Cell Therapy Trials
    • Sustainable Manufacturing
    • Bioprocessing Trends
    • How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login